Results 1 to 10 of about 63,836 (336)
Immunophenotyping beyond the limits of time
Cell Reports: Methods, 2023 Immunophenotyping is a powerful approach for deciphering responses of the immune system to drug screening and immunotherapy. In this issue of Cell Report Methods, Liechti et al.
J. Fréderique de Graaf, Ramon Arens
doaj +3 more sources
T-Cell Subsets Predict Mortality in Malnourished Zambian Adults Initiating Antiretroviral Therapy. [PDF]
, 2015 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are creditedTo estimate the ...
Chisenga, CC +5 more
core +16 more sources
Multiparameter Flowcytometry for Diagnosis and Subtyping of Mature Lymphocytic Neoplasms in Peripheral Blood and Bone Marrow: A Prospective Observational Study [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Multiparameter Flowcytometry (MFC) is a high throughput, quick, and practical technique for diagnoses of Chronic Lymphoproliferative Disorders (CLPDs). Indian CLPDs cases have distinct distribution and presentation than the developed world.
Shailendra Jambhulkar +5 more
doaj +1 more source
Carboxypeptidase A3—A Key Component of the Protease Phenotype of Mast Cells
Cells, 2022 Carboxypeptidase A3 (CPA3) is a specific mast cell (MC) protease with variable expression. This protease is one of the preformed components of the secretome.
Dmitri Atiakshin +5 more
doaj +1 more source
Pharmaceuticals, 2023 The mechanisms of regeneration for the fibrous component of the connective tissue of the dermis are still insufficiently studied. The aim of this study was to evaluate the effectiveness of the use of molecular hydrogen on the local therapy of a II degree
Dmitri Atiakshin +8 more
doaj +1 more source
Pharmaceuticals, 2023 Knowledge of the biological effects of molecular hydrogen (H2), hydrogen gas, is constantly advancing, giving a reason for the optimism in several healthcare practitioners regarding the management of multiple diseases, including socially significant ones
Dmitri Atiakshin +8 more
doaj +1 more source
The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders
British Journal of Biomedical Science, 2023 Background: B-Cell Lymphoproliferative Disorders (B-LPDs) are a group of heterogenous disorders characterised by the accumulation of B-cells in peripheral blood, bone marrow, lymph nodes and spleen.
Hanaan Kareem Al-Zubaidi +1 more
doaj +1 more source
The Journal of Qazvin University of Medical Sciences, 2023 Background:Acute lymphoblastic leukemia (ALL) is the most prevalent childhood cancer. ALL is a heterogeneous type of malignancy and treatment protocols vary based on the immunological classification of ALL.
Majid Vafaie +3 more
doaj +1 more source
Frontiers in Oncology, 2020 Undetectable minimal residual disease (MRD) in Chronic Lymphocytic Leukemia (CLL) has a favorable prognostic outcome compared with MRD that can be detected.
Timothy W. Farren +4 more
doaj +1 more source
Frontiers in Oncology, 2023 Chronic lymphocytic leukemia (CLL) is a subtype of mature B-cell proliferative neoplasms characterized by abnormally increasing lymphocytes in circulation.
Yuan Ren +5 more
doaj +1 more source